VINEET LABORATORIES share price has plunged 10% and is presently trading at Rs 58.2.
Meanwhile, the BSE HEALTHCARE index is at 40,920.8 (down 0.3%).
Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 2.6%) and Biocon (down 1.8%).
AJANTA PHARMA (up 3.1%) and Glenmark Pharma (up 1.3%) are among the top gainers today.
Over the last one year, VINEET LABORATORIES has moved up from Rs 51.7 to Rs 58.2, registering a gain of Rs 6.4 (up 12.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,920.8, registering a gain of 47.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.6%), GSK Pharma (up 100.5%) and SUVEN PHARMACEUTICALS (up 95.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,103.9 (up 0.2%).
The top gainers among the BSE Sensex today are TCS (up 1.5%) and M&M (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.
In the meantime, NSE Nifty is at 24,157.1 (up 0.1%). TCS and M&M are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,103.9, registering a gain of 13,702.0 points (up 21.0%).
VINEET LABORATORIES net profit fell 45.8% YoY to Rs 19 million for the quarter ended March 2024, compared to a profit of Rs 35 million a year ago. Net sales declined 35.2% to Rs 370 million during the period as against Rs 572 million in January-March 2023.
For the year ended March 2023, VINEET LABORATORIES reported 81.1% decrease in net profit to Rs 13 million compared to net profit of Rs 66 million during FY22. Revenue of the company grew 11.0% to Rs 2,123 million during FY23.
The current Price to earnings ratio of VINEET LABORATORIES, based on rolling 12 month earnings, stands at 52.3.
Equitymaster requests your view! Post a comment on "VINEET LABORATORIES Plunges 10%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!